Zobrazeno 1 - 10
of 93
pro vyhledávání: '"C, Cavalieri"'
Publikováno v:
Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, Vol 12, Iss 1 (2024)
Diabetic retinopathy (DR) is considered to be a leading cause of blindness in people aged 16 to 64 years, affecting around 40% of the population diagnosed with diabetes mellitus (DM). DR is usually identified through retinal image analysis, and in so
Externí odkaz:
https://doaj.org/article/d6dd590ee32d4d118fae9397a8415ed8
Autor:
Marta Amorim, Frederico D. Bortoloti, Patrick M. Ciarelli, Evandro O. T. Salles, Daniel C. Cavalieri
Publikováno v:
IEEE Access, Vol 7, Pp 132786-132802 (2019)
This work aims to propose an approach for detecting novelties, taking into account the temporal flow of data streams in social media. To this end, we present a completely new architecture for novelty detection. This new architecture entails three new
Externí odkaz:
https://doaj.org/article/cf92f35268b44f27ab9465a4c845bcd6
Autor:
David D Stenehjem, Courtney C Cavalieri, Eric Swanson, Benjamin Solomon, Jonathan Whisenant, Dao Tran, John Weis, G Weldon Gilcrease, Sunil Sharma, Ignacio Garrido-Laguna
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 1-6 (2018)
Background: Tumors with deficient mismatch repair (dMMR) have a favorable immunological phenotype permitting exploitation by immunotherapies. We aimed to assess our institutional experience of dMMR advanced gastrointestinal (GI) cancers treated with
Externí odkaz:
https://doaj.org/article/518196c78f6e47e7b0d8093b057286ec
Autor:
Vaia Florou, Kristin E Barber, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna, Jenna N Mastroianni, Courtney C. Cavalieri
Publikováno v:
JCO Precis Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce72c3d5591fb5ca81a261f0bb42b4eb
https://doi.org/10.1200/po.20.00052
https://doi.org/10.1200/po.20.00052
Autor:
Mona Foth, Courtney C. Cavalieri, Lance D. Burrell, Stephanie L. Cutler, Conan G. Kinsey, Kajsa E. Affolter, Jill E. Shea, Amelie M. Boespflug, Kaitrin M. Rehbein, Alana L. Welm, Jeffrey T. Yap, Bryan E. Welm, Michael T. Seipp, Sophia S. Schuman, Jonathan Whisenant, G. Weldon Gilcrease, Amanda Truong, David H. Lum, Katrin P. Guillen, Courtney L. Scaife, Martin McMahon, Eric L. Snyder, Soledad A. Camolotto
Publikováno v:
Nature medicine
Pancreatic ductal adenocarcinoma (PDA) was responsible for ~ 44,000 deaths in the United States in 2018 and is the epitome of a recalcitrant cancer driven by a pharmacologically intractable oncoprotein, KRAS1–4. Downstream of KRAS, the RAF→MEK→
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa5167ad697961fda688a1d48e6be90
https://doi.org/10.1038/s41591-019-0367-9
https://doi.org/10.1038/s41591-019-0367-9
Autor:
Benjamin Solomon, Jonathan Whisenant, Courtney C. Cavalieri, G. Weldon Gilcrease, Ignacio Garrido-Laguna, David D. Stenehjem, John R. Weis, Sunil Sharma, Dao Tran, Eric R. Swanson
Publikováno v:
Journal of Immunotherapy and Precision Oncology. 1:1-6
Background: Tumors with deficient mismatch repair (dMMR) have a favorable immunological phenotype permitting exploitation by immunotherapies. We aimed to assess our institutional experience of dMMR advanced gastrointestinal (GI) cancers treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de0090ceecc23c1dc32aadb91b2bcab0
https://doi.org/10.4103/jipo.jipo_5_18
https://doi.org/10.4103/jipo.jipo_5_18
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Oncology Pharmacy Practice. 23:602-614
Clinical pharmacists are important contributors to the care of patients with cancer; it is therefore critical for oncology clinical pharmacists to stay current with new anticancer therapies. This review summarizes the epidemiology and pathogenesis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172baae7e59162c6c465bd183530a253
https://doi.org/10.1177/1078155216672315
https://doi.org/10.1177/1078155216672315
Autor:
Alana L. Welm, Mona Foth, Courtney C. Cavalieri, Martin McMahon, Jill E. Shea, Stephanie L. Cutler, Conan Kinsey, Michael T. Seipp, Weldon Gilcrease, Kajsa E. Affolter, Bryan E. Welm, Eric L. Snyder, Kaitrin M. Rehbein, Jonathan Whisenant, Amelie M. Boespflug, Jeffrey T. Yap, Katrin P. Gullien, Lance D. Burrell, Soledad A. Camolotto, David H. Lum, Courtney L. Scaife
Publikováno v:
Molecular Cancer Research. 18:A45-A45
Pancreatic ductal adenocarcinoma was responsible for ~43,000 deaths in the USA in 2017 and is the epitome of a recalcitrant cancer driven by a pharmacologically intractable oncoprotein, KRAS. Although the clinical picture remains grim, the mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba407278220eac1a113ee4dae1d42260
https://doi.org/10.1158/1557-3125.ras18-a45
https://doi.org/10.1158/1557-3125.ras18-a45